Association of a GSK-3β polymorphism with brain resting-state function in amnestic-type mild cognitive impairment.

doi:10.3233/JAD-2012-120631

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Association of a GSK-3β polymorphism with brain resting-state function in amnestic-type mild cognitive impairment.

Journal of Alzheimer's disease : JAD - 1 Jan 2012

Bai Feng, Shi Yongmei, Yuan Yonggui, Yue Chunxian, Zhuang Liying, Xu Xiaohui, Liu Xiaoyan, Zhang Zhijun

Abstract excerpt

The glycogen synthase kinase-3β (GSK-3β) gene has been implicated in Alzheimer's disease (AD). Polymorphisms in this gene are plausible modulators of brain function. However, little is known about the potential role of the GSK-3β rs334558 polymorphism, which has been associated with amnestic mild cognitive impairment (aMCI), which is itself associated with a high risk of AD. In this study, 43 aMCI patients and 30...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Brain Mapping

Share to Cognitive Dysfunction

Share to Glycogen Synthase Kinase 3

Share to Glycogen Synthase Kinase 3 beta

Share to Image Processing, Computer-Assisted

Share to Magnetic Resonance Imaging

Share to Neuropsychological Tests

Source

Open in PubMed

Identifiers

PMID: 22785398
DOI: 10.3233/JAD-2012-120631

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of a GSK-3β polymorphism with brain resting-state function in amnestic-type mild cognitive impairment.PMID 22785398Read ↗

Multiple genetic imaging study of the association between cholesterol metabolism and brain functional alterations in individuals with risk factors for Alzheimer's disease.Semantic proximity Read ↗

The association between TOMM40 gene polymorphism and spontaneous brain activity in amnestic mild cognitive impairment.Semantic proximity Read ↗

APOE Genotype Effects on Intrinsic Brain Network Connectivity in Patients with Amnestic Mild Cognitive Impairment.Semantic proximity Read ↗

Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.Semantic proximity Read ↗

Cortical Thickness and Microstructural White Matter Changes Detect Amnestic Mild Cognitive Impairment.Semantic proximity Read ↗

A combined study of GSK3β polymorphisms and brain network topological metrics in major depressive disorder.Semantic proximity Read ↗

Association of GSK-3β genetic variation with GSK-3β expression, prefrontal cortical thickness, prefrontal physiology, and schizophrenia.Semantic proximity Read ↗

Association of the interleukin 1 beta gene and brain spontaneous activity in amnestic mild cognitive impairment.Semantic proximity Read ↗

GSK-3β activation mediates apolipoprotein E4-associated cognitive impairment in type 2 diabetes mellitus: A multicenter, cross-sectional study.Semantic proximity Read ↗

Cognitive reserve and gamma entrainment-related network changes in prodromal Alzheimer’s diseaseSemantic proximity Read ↗

Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity.Semantic proximity Read ↗

Interactions between GSK3β and amyloid genes explain variance in amyloid burden.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.